It took a pivot, but silk-based products are on the way for startup Cocoon

As an entrepreneur, Ailis Tweed-Kent was well aware that not all startup business models, particularly those in the life sciences, survive the test of time, or the science, or the market. Sure enough, three years after founding Cocoon Biotech Inc., Tweed-Kent and her small team realized that the goal of developing new treatments for osteoarthritis by leveraging silk as a drug-delivery material just wasn’t going to work as planned. But they did discover during their early-stage re search that silk…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news